- Home
- MRNA vs CF Comparison
MRNA vs CF Comparison
Compare MRNA & CF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- CF
- Stock Information
- Founded
- MRNA 2010
- CF 1946
- Country
- MRNA United States
- CF United States
- Employees
- MRNA N/A
- CF N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- CF Agricultural Chemicals
- Sector
- MRNA Health Care
- CF Industrials
- Exchange
- MRNA Nasdaq
- CF Nasdaq
- Market Cap
- MRNA 16.5B
- CF 14.3B
- IPO Year
- MRNA 2018
- CF 2005
- Fundamental
- Price
- MRNA $36.85
- CF $87.03
- Analyst Decision
- MRNA Hold
- CF Hold
- Analyst Count
- MRNA 17
- CF 12
- Target Price
- MRNA $87.67
- CF $87.45
- AVG Volume (30 Days)
- MRNA 8.4M
- CF 1.8M
- Earning Date
- MRNA 11-07-2024
- CF 10-30-2024
- Dividend Yield
- MRNA N/A
- CF 2.30%
- EPS Growth
- MRNA N/A
- CF N/A
- EPS
- MRNA N/A
- CF 6.29
- Revenue
- MRNA $5,081,000,000.00
- CF $5,983,000,000.00
- Revenue This Year
- MRNA N/A
- CF N/A
- Revenue Next Year
- MRNA N/A
- CF $1.38
- P/E Ratio
- MRNA N/A
- CF $13.84
- Revenue Growth
- MRNA N/A
- CF N/A
- 52 Week Low
- MRNA $35.80
- CF $69.13
- 52 Week High
- MRNA $170.47
- CF $90.86
- Technical
- Relative Strength Index (RSI)
- MRNA 12.62
- CF 58.74
- Support Level
- MRNA $41.54
- CF $82.47
- Resistance Level
- MRNA $56.70
- CF $87.77
- Average True Range (ATR)
- MRNA 2.95
- CF 2.24
- MACD
- MRNA -1.05
- CF 0.27
- Stochastic Oscillator
- MRNA 4.80
- CF 72.55
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CF CF Industries Holdings Inc.
CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally. The company is also investing in carbon-free blue and green ammonia, which can be used an alternative fuel to hydrogen or as a means to transport hydrogen.